Acne Treatment Market Share, Scope, Growth, Trends And Forecast

Increasing prevalence of acne, growing teenage population, rising cosmetic expenditures, and increasing awareness of the skin condition is estimated to drive the acne treatment market across the globe during the forecast period. On the other hand, reported cases of serious reaction caused by the non-prescription acne care products and the high cost of therapeutic procedures like microdermabrasion, dermabrasion, and others is estimated to restraint the market growth during the projected period.

Request Sample Copy:

https://www.marketresearchfuture.com/sample_request/5675

Segmentation

The global acne treatment market is segmented on the basis of type, treatment, treatment modality, and end users. On the basis of the type, the market is segmented into comedonal acne, inflammatory acne, cystic acne, post-surgical/wound acne, and others. On the basis of treatment, the market is categorized into medication, therapeutic devices, and others. The medication segment is-sub segmented into retinoid, antibiotics, and others. The retinoid segment is further segmented into adapalene, tretinoin, others. The antibiotics segment is further segmented into erythromycin, clindamycin, and others. The therapeutic devices segment is sub-segmented into lasers, microdermabrader, dermabradors, and others.  On the basis of treatment modality, the market is segmented into oral, topical, injectable. On the basis of end users, the market is segmented into hospitals & clinics, pharmacies & drug stores, ambulatory surgical centers, and others.

Regional Analysis

America dominates the Acne Treatment Market Share owing to a well-developed healthcare sector and a huge patient population within the region. Moreover, changing lifestyle and increasing cosmetic expenditure provides a boost to the market growth in the Americas.  Europe holds the second largest market for acne treatment across the globe due to availability of funds for research, a huge patient population and increasing teenage population within the region. Asia Pacific is projected to be the fastest growing region for the market for acne treatment. This can be attributed due to increasing prevalence of acne, and continuously developing economies like India and China within the region. Additionally, a developing healthcare sector within the region fuels the market growth. On the other hand, the Middle East & Africa holds the least share in the global acne treatment market. Presence of poor economies, stringent government policies and lack of healthcare services are the factors restraining the growth of the market within the region. It is estimated that a majority of the acne treatment market within the Middle East and Africa is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure by the developed economies like Saudi Arabia, Dubai, Kuwait within the region.

Key Players

The key players for the global acne treatment market are ALLERGAN (Republic of Ireland), Galderma S.A. (Switzerland), Stiefel Laboratories, Inc. (U.S.), Valeant (Canada), Johnson & Johnson Services, Inc. (U.S.), GlaxoSmithKline Plc. (U.K), Teva Pharmaceutical Industries Ltd. (Israel), Bayer AG (Germany), Roche Holding AG (Switzerland), and others.

For More Details

https://www.marketresearchfuture.com/reports/acne-treatment-market-5675

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Pulmonary Edema Treatment Market Analysis: Potential growth, attractive valuation make it is a long-term investment | Top Players

Market Highlights

Increasing prevalence of pulmonary edema and diseases like kidney failure, heart diseases, and others along with the growing geriatric population boosts the market growth. On the other hand, low per capita healthcare expenditure in the middle and low-income countries, and lack of awareness about the disease are estimated to restrain the market growth.

The global pulmonary edema market is expected to grow at an approximate CAGR of 7.2% during the forecast period.

Request Sample Copy:

https://www.marketresearchfuture.com/sample_request/5607

Segmentation

The global pulmonary edema market is segmented on the basis of type, diagnosis, treatment, and end user. On the basis of the type, the market is segmented into cardiogenic edema, cardiogenic edema, and others. On the basis of the diagnosis, the market is categorized into blood tests, imaging, and others. The blood tests segment is sub-segmented into b-type natriuretic peptide (BNP), blood count test, kidney function test, and others. The imaging segment is sub-segmented into chest x-ray, electrocardiogram, echocardiogram, transesophageal echocardiography, pulse oximetry, and others. On the basis of the treatment, the market is segmented into preload reducers, morphine, suction catheter, and others. The preload reducers segment is sub-segmented into nitroglycerin, diuretics, and others. On the basis of the end users, the market is segmented into hospitals & clinics, academic institutes, retail pharmacies, and others.

Regional Analysis

America dominates the global Pulmonary Edema Treatment Market Analysis due to the presence of a well-developed healthcare sector, high per capita healthcare expenditure and developed economies such as the U.S. and Canada within the region. Additionally, global players such as Pfizer Inc., Edwards Lifesciences Corporation, ARGON MEDICAL, and others within the region boost the market. Europe holds the second major market for pulmonary edema, followed by the Asia Pacific owing to the availability of funds for research and  presence of developed economies like France, Italy, Germany within the region along with the growing geriatric population. Asia Pacific is the fastest growing region for the global pulmonary edema market due to rising healthcare expenditure, favorable government policies, and huge patient population. The Middle East & Africa has the least share in the global pulmonary edema market.  Presence of poor economies and stringent government policies especially within in the African region retains the regional market growth. A majority of the market in the region is held by the Middle East due to huge healthcare expenditure and presence of developed healthcare sector.

Key Players

Pfizer Inc. (U.S.), ARGON MEDICAL (U.S.), Edwards Lifesciences Corporation (U.S.), BD (U.S.), Alcaliber S.A. (Spain), Lupin Pharmaceuticals, Inc. (India), Vitaltec Corporation (China), Medtronic (U.S.), Koninklijke Philips N.V. (The Netherlands), Siemens Healthcare GmbH (Germany), Hitachi Medical Corporation (U.S.), CANON MEDICAL SYSTEMS CORPORATION (Japan), others.

Access Report Details @ 

https://www.marketresearchfuture.com/reports/pulmonary-edema-market-5607

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Medical Supplies Market by Scope, Demand, Growth, Recent Developments & Emerging Trends

A new market study, titled “Medical Supplies Market Research Report- Global Forecast To 2022” has been featured on Market Research Future (MRFR)

The global medical supplies market is predicted to touch USD 132 billion at a notable CAGR over the forecast period (2017-2022), as per the latest Market Research Future (MRFR) report. Medical supplies, simply put, is another term for medical equipment. It is of various types including consumable medical supplies or disposable supplies, life-saving equipment, electronic supplies, diabetic supplies, home healthcare supplies, surgical supplies, acute care supplies, durable medical equipment, diagnostic and testing supplies and equipment, and many more. Every variety has distinct features and characteristics which aid them in performing the task that they are intended for.

Also Read: https://www.medgadget.com/2020/06/medical-supplies-market-size-worth-usd-132-billion-by-2022-growth-projection-latest-trends-regional-outlook-and-covid-19-impact-analysis-on-medical-supplies-industry.html

Various factors are propelling the medical supplies market. These factors, according to the latest MRFR report, include rising geriatric population, rising incidences of different diseases, increasing number of surgeries, rising patient pool for renal diseases, and growing incidence of hypertension and diabetes. Additional factors pushing market growth include the growing use of dialysis procedures, availability of more effective and technologically advanced products, increasing investments in the healthcare sector, increase in surgery rates, increasing adoption of new surgical procedures, and growing awareness about preventative care.

Market Segmentation

The Market Research Future report provides a wide segmental analysis of the medical supplies market based on type, application, and end user.

Based on type, the medical supplies market is segmented into adult continence products, blood glucose test strips, surgical drapes, dialysis consumables, wound care products, blood collection tubes, infusion products, and others. Of these, the dialysis consumables segment will have the largest share in the market over the forecast period. It is predicted to grow at the highest CAGR owing to rising adoption of dialysis procedures, growing geriatric population, rising incidence of hypertension and diabetes, and rising patient pool for renal diseases.

Based on application, the medical supplies market is segmented into anesthesia, sterilization, wound care, and others. Of these, the anesthesia segment will dominate the market over the forecast period. This is owing to the rising cases of respiratory diseases and the rising number of surgical procedures being performed across the world.

Based on end user, the medical supplies market is segmented into nursing homes, clinics, hospitals, and others. Of these, the hospitals segment will lead the market over the forecast period. This is owing to the rising incidences of chronic diseases worldwide, rising prevalence of HAIs, and rising investment in healthcare systems.

For More Details: https://www.marketresearchfuture.com/reports/medical-supplies-market-2433

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Spinal Implants Market by Scope, Demand, Growth, Recent Developments & Emerging Trends

This research report represents a 360-degree overview of the competitive landscape of the “Spinal Implants Market Research Report – Global Forecast To 2022”

According to Market Research Future’s newest report on the global spinal implants, market reveals that the market is anticipated to grow at a CAGR of 5.5% during the forecast period of 2017 to 2023. Used extensively to treat spinal deformities and other common spinal issues that may occur with age, the market is expected with witness moderate and consistent growth over the assessment period.

Also Read

Age-related wear and tear often result in spinal problems such as spinal stenosis. The presence of a globally growing geriatric population is expected to drive the demand for spinal implants. Urbanization has led to increasingly sedentary lifestyles which aggravate spinal problems, thus resulting in increasing diagnoses of chronic back pain; as such, the demand for spinal implants is expected to grow significantly. Development of advanced technology and spinal implants which combined with the growing demand for minimally invasive spinal surgeries have resulted in cost-effective spinal implants are expected to increase demand for the same.

Market Segmentation

The global spinal implants market has been segmented based on product, procedure, material, and region. By product, the market is segmented into vertebral compression fracture (VCF) treatment devices, non-fusion devices/motion preservation devices, spinal fusion devices, spine biologics, spinal bone stimulators, and others. The spine fusion segment is further segment is divided into cervical fixation devices, thoracolumbar devices, interbody fusion devices, and others.  Confusion devices/ motion preservation devices are further segmented into non-bone interbody fusion devices and bone interbody fusion devices.

Vertebral compression fracture (VCF) treatment devices have been sub-segmented into balloon kyphoplasty devices and vertebroplasty devices. spinal bone stimulators are sub-segmented into non-invasive spine bone stimulators and invasive spine bone stimulators. Spine biologics are sub-segmented into spinal allografts, bone graft substitutes, and cell-based matrix. Further sub segmentations are included in the report.

By procedure, the market is segmented into open surgery, minimally invasive surgery, and others.

By material, the market is segmented into titanium alloy, titanium, plastic, stainless steel, and others.

The global spinal implants market is divided into the Americas, Europe, Asia Pacific, and the Middle East and Africa.

Key Players

Market players included in MRFRs competitive analysis include Depuy Synthes Inc. (Johnson & Johnson), Medtronic, plc, A-Spine, Stryker Corporation, Alphatec Holdings, Inc., Quandary Medical LLC, Spine Frontier, Apollo Spine, Precision Spine, Premia Spine, K2M Group Holdings, Inc., Exactech Inc., Integra LifeSciences, SI-BONE, Reliance Medical Systems, AESCULAP, Zimmer Biomet Holdings, Inc., Globus Medical, Inc., NuVasive, Inc., Life Spine, Orthofix International N.V., SpineGuard, Spinal Solutions Inc., Spineart Geneva SA, Accel Spine, Captiva Spine Inc., Back 2 Basics Spine, RTI Surgical, Inc., Centinel Spine, NLT Spine, Paradigm Spine LLC, Ascendx Spine, Amedica Corporation, LDR Holding Corporation, Alliance Spine and others

For More Details:

https://www.marketresearchfuture.com/reports/spinal-implants-market-2050

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Botulinum Toxin Market Global Analysis, Research, Review, Applications and Forecast

The report begins with the overview of the “Global Botulinum Toxin Market Research Report—Forecast till 2025” and offers throughout development. It presents a comprehensive analysis of all the regional analysis.

Botulinum Toxin Market is expected to register a CAGR of 10.3% during the forecast period, with a market value of USD 9,442.93 Million by 2025. Botulinum toxin is known as one of the most poisonous biological substance. It is a neurotoxin produced by the bacterium Clostridium botulinum. There are seven distinct forms of botulinum toxin, types A–G. Four of these (types A, B, E, and rarely F) cause human botulism. Botulinum toxin A and B are used for therapeutic and aesthetic procedures. The increasing cases of spasticity, cervical dystonia and chronic migraine, surge in demand for facial aesthetic, and rising number of product launches and approvals by key players are likely to drive the growth of the global botulinum toxin market during the forecast period.

Also Read:

Segment Analysis

The Global Botulinum Toxin Market, by type, has been segmented into botulinum toxin type A and B. Rising adoption of botulinum toxin in aesthetic procedures as compared to tissue fillers and increasing product approvals by regulatory authorities is anticipated to drive the growth of this segment during the forecast period. As per the Plastic Surgery Statistics Report published in 2018 by the American Society of Plastic Surgeons, the number of cosmetic minimally-invasive procedures involving the use of botulinum toxin type A was 7.43 million in 2018, whereas the processes involving the use of soft tissue fillers were 2.67 million in 2018 in the US.

The Global Botulinum Toxin Market, by application segment, has been segmented into therapeutic application and aesthetics applications. The therapeutics segment has been further divided into a chronic migraine, spasticity, cervical dystonia, overactive bladder, blepharospasm, and others.

Based on end-user, the global botulinum toxin market has been classified into dermatology centers, hospitals & clinics, and others.

Regional Analysis

The Botulinum Toxin Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is likely to hold the largest share of the global botulinum toxin market. The Americas is divided into North America and Latin America. North America has been further subdivided into the US and Canada. The increasing product approvals, rising cases of spasticity, and the presence of major manufacturers such as US WorldMeds, LLC., Evolus, Inc., Hugel, Inc., and Revance Therapeutics, Inc. in the region are expected to drive the market growth in this region.

Europe established substantial growth in the market owing to rising botulinum toxin procedures and the presence of developed economies such as Germany, the UK, and France. Additionally, there is an increasing demand for minimally invasive cosmetic procedures to enhance the young-looking appearance, which in turn is driving the growth of the market in this region.

Asia-Pacific is estimated to be the fastest-growing region in the global market due to the growing geriatric population, rising per capita disposable income, developing healthcare infrastructure, medical tourism, booming entertainment industry, and rising investments by major players in the regional market are likely to drive the growth of the market.

The botulinum toxin market in the Middle East & Africa is expected to grow due to the rising awareness about botulinum toxin coupled with developing healthcare infrastructure and rising demand for products from countries like Saudi Arabia and UAE.

Key Players

MRFR recognizes the following companies as the Key Players in the Global Botulinum Toxin Market— Allergan PLC, Merz Pharma GmbH & Co KGaA, Galderma S.A., Daewoong Pharmaceutical Co., Ltd, Ipsen Pharma, US WorldMeds, LLC. (Solstice Neurosciences, LLC), Evolus, Inc., Hugel, Inc, Medytox, Revance Therapeutics, Inc., and others.

Key Findings of the Study

The Global Botulinum Toxin Market is estimated to grow at USD 9,442.93 Million by 2025 at a CAGR of 10.3% during the assessment period

Americas accounted for the largest share of the global market due to the presence of key market players and the rising number of aesthetic procedures

Based on the type, the botulinum toxin type A segment accounted for the largest market share of 29% in 2018

Global Botulinum Toxin Market based on application is dominated by therapeutic segment with 55.84% market share

Based on end-user, the dermatology centers segment held a market share of 52.63% in 2018

For More Details @

https://www.marketresearchfuture.com/reports/botulinum-toxin-market-8567

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Healthcare Data Storage Market Insights By Growth, Opportunities, Trends, Drivers, Challenges, Forecast

The report begins with the overview of the “Global Healthcare Data Storage Market Research Report—Forecast till 2025” and offers throughout development. It presents a comprehensive analysis of all the regional analysis.

 Market Highlights

According to MRFR analysis, Healthcare Data Storage Market is expected to register a CAGR of 13.9% during the forecast period of 2019 to 2025 and is likely to be valued at USD 48.2 Billion in 2025. Healthcare data storage are software solutions used by hospitals, clinics, diagnostic centers to store patient data for future use. These solutions are used by healthcare companies to store data about manufacturing products and their processes.

Also Read:

The growth of the global healthcare data storage market is determined by numerous factors such as an increasing patient database due to the increasing number of surgeries, increasing clinical trials, and research activities to develop innovative products. Also, the decreasing paper use to maintain patient information increases the demand for healthcare data storage solutions.  However, the key factors such as data infringement, cyber-attacks and high cost of healthcare data storage solution hamper the market growth. 

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

Americas has been segmented into North America and Latin America, with the North American market being divided into the US and Canada. The Americas is projected to hold the largest market share owing to the increasing burden of clinical data, which is challenging to handle drives the market growth during the forecasted period.  

The European healthcare data storage market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Italy, Germany, Spain, France, the UK, and the rest of Western Europe. The healthcare data storage market in Asia-Pacific has been segmented into Japan, India, China, Australia, South Korea, and the rest of Asia-Pacific.  Due to the rising geriatric population and the presence of a large patient pool, the market in Asia-Pacific is expected to be the fastest-growing. The healthcare data storage market in the Middle East & Africa has been divided into the Middle East and Africa.

Segmentation

The Global Healthcare Data Storage Market has been segmented based on solution, application, architecture, type, storage system, and end user.

The market, based on solution, has been divided into on-premise, cloud, and hybrid data storage. On-premise is likely to hold the maximum market share in the global healthcare data storage market.

The Global Healthcare Data Storage Market on the basis of application has been segregated into the clinical analysis, financial analysis, and operational analysis. The clinical analysis segment is expected to hold a larger share of the market share owing to the rising number of hospitals, clinics, and diagnostic centers. Clinical analysis is further sub-segmented into clinical decision support, quality control, reporting and compliance, population health management, and precision health. The financial analysis is further segmented into revenue cycle management, claim processing, risk adjustment & assessment, and others.

On the basis of architecture is segmented into file storage, object storage, and block storage.

Based on type, the market is segmented into flash & solid-state storage and magnetic storage. The magnetic storage is further sub-segmented into magnetic disks and magnetic tapes.

On the basis of storage system, the market is segmented into storage area network and network-attached storage direct-attached storage.

The end user segment of the market consists of hospitals and clinics, pharmaceutical & biotechnology companies, clinical/contract research organizations (CROs), and contract manufacturing organizations (CMOs), and others.

Key Players

Some of the Key Players in the Global Healthcare Data Storage Market are DataCore Software (US), Dell Inc. (US), IBM Corporation (US), NetApp (US), Hewlett Packard Enterprise (HPE)(US), Pure Storage (US), Hitachi (Japan), Western Digital (US), Nuance Communications, Inc (US), and Carestream Corporation (US).

Browse Full Report Details @ 

https://www.marketresearchfuture.com/reports/healthcare-data-storage-market-8572

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Laboratory Information Systems Market – Global Industry Analysis, Trends, Growth opportunities and Demand Forecast

The research report analyzes the “ Laboratory Information Systems Market Research Report – Global Forecast to 2025 ” in a detailed and concise manner for better insights into the businesses

Laboratory Information Systems Market – Overview

Laboratory information system (LIS) is a comprehensive information system developed and configured to process, store, and manage information pertaining to industrial and medical-related laboratories which include clinical and analytical laboratories. LIS plays an important role in streamlining the process and generating high quality data to support effective clinical decisions. The LIS provides information that helps hospitals in the diagnosis, prevention, management, and treatment of diseases, and acts an indicator for public health. The LIS has now emerged as a necessity for both small and large diagnostic and drug companies’ laboratories. The ability of both clinical and analytical laboratories to better manage data and incorporate collaborative technological tools into their day-to-day operations has become critical to remain competitive.

Also Read:

https://www.globenewswire.com/news-release/2019/07/30/1893765/0/en/Laboratory-Information-Systems-Market-To-Witness-a-CAGR-Exceeding-7-3-By-2027-Predicts-Market-Research-Future.html

LIS, used in both large- and small-scale companies, provide a platform to automatically obtain, store and archive information, track samples, and generate reports efficiently. The LIS products vary widely in terms of cost, sophistication, and industrial focus. As industrial and medical laboratories are diverse with different requirements, hence, there is no standard information system designed for laboratories. Therefore, a LIS is customized, developed, and configured according to the requirements of a laboratory.

Major components of LIS are hardware, software and services. Hardware mainly includes servers as well as data input, output and storage devices. Software includes the interface of integrated LIS which helps managing and analysing data in an efficient manner. Whereas, the key delivery modes used for LIS, include web based, on premise, mobile solutions and cloud based technology.

The global LIS market is expected to grow at a CAGR of 7.3% between 2016 and 2027, driven by growth from both developed and emerging markets.

Global Laboratory Information Systems Market – Regional:

 Cerner Corporation, Eclipsys Corporation, LabVantage Solutions Inc, LabWare Inc., McKesson Corporation, Medical Information Technology Inc., Merge Healthcare Inc., STARLIMS Corporation, Sunquest Corporation and Thermo Fisher Scientific Inc. are some of the prominent players at the forefront of competition in the global laboratory information systems market and are profiled in MRFR Analysis.

Geographically, the regional market is segmented into America, Europe, Asia Pacific, and the Middle East & Africa.

 The North America dominated the global Laboratory Information Systems market. The adoption of cloud computing is expected to rise in the U.S. healthcare sector due to continuous pressure to lower cost for customized healthcare services. According to clauses of the HIPAA, the healthcare industry in the U.S. has to adopt new systems that support electronic medical records (EMR) and share data in an efficient and secure manner with other healthcare providers and government agencies. This will lead to higher adoption of cloud-based LIS, which allow laboratories to share real-time information with hospitals and patients. In terms of LIS usage, North American and Western European markets are witnessing penetration, due to early adoption of healthcare technologies.

The European LIS market is expected to grow moderately, driven by higher incidence rate of diseases and increasing patient awareness about new technologies. In addition, various government initiatives also helped in promoting the usage of LIS. Increasing demand for better healthcare facilities and rising need for integrated healthcare systems in the two regions are some of the key driving factors for these markets.

The LIS market is expected to grow in Asia-Pacific (APAC) due to increase in the incidences of diseases. Asia and Latin America are among the fastest growing markets for LIS; rising investments from healthcare IT players and government initiatives are some of the key driving factors for LIS in these regions. Many international LIS firms have started investing in developing regions of the world, such as Asia and Latin America, in order to increase their presence in high potential markets.

Browse Full Report @ 

https://www.marketresearchfuture.com/reports/laboratory-information-systems-market-852

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Medical Oxygen Concentrators Market With Trends, Growth, Scope, Size, Overall Analysis and Prognostication

This research report represents a 360-degree overview of the competitive landscape of the “Medical Oxygen Concentrators Market Research Report – Global Forecast till 2024”.

Market Highlights

The Global Medical Oxygen Concentrators Market held a market value of USD 1,755.8 Million in 2018 and is Projected to Grow at a CAGR of 7.8% Over the Forecast Period. Oxygen concentrator, also called as oxygen generator is a medical device used to deliver oxygen to the patient. This device concentrates the oxygen from a gas supply by removing nitrogen to supply an oxygen-enriched product gas stream. Stationary oxygen concentrators are used as stationary sources to provide long-term oxygen therapy (LTOT) to patients at home. Oxygen concentrators provide supplementary oxygen for patients suffering from a chronic obstructive pulmonary disease (COPD) and in higher concentrations for pulmonary edema and severe chronic hypoxemia. In addition, this device is also used as an adjunct treatment for severe sleep apnea.

Also Read:

Portable oxygen concentrators are oxygen machines that draw in oxygen with the use of a battery, electricity or DC power. These oxygen concentrators offer advantages such as compact in size, lightweight, improved efficiency, cost economic price, and mobility that enables patients to travel hassle-free. Technological advancements in the portable oxygen concentrators include pressure swing adsorption (PSA), and membrane technology is helping in the swift adoption of portable medical oxygen concentrators.

Segmentation

The global medical oxygen concentrators market has been segmented into product, technology, indication, end user, and region.

By product, the market has been segmented into portable oxygen concentrators and stationary oxygen concentrators.

On the basis of technology, the market has been divided into the continuous flow and pulse dose.

Based on indication, the market has been categorized into chronic obstructive pulmonary disease, asthma, sleep apnea, and others.

By end user, the market has been classified into homecare, travel, hospitals and clinics, and others. Home oxygen concentrators facilitate convenience and make it easier and safer for the patient to complete their day-to-day activities, which is supporting the dominance of the homecare segment during the next six years.

Key Players

Few of the prominent players in the global medical oxygen concentrators market are Philips Healthcare, AirSep Corporation, Invacare Corporation, Drive DeVilbiss Healthcare, Medtronic plc, ResMed, Chart Industries, Inc., Nidek Medical Products, Inc., Inogen, Precision Medical, Inc., GCE Group, Besco Medical Limited, O2 Concepts, LLC, Teijin Limited, and OSI – Oxygen Solutions Inc.

Regional Analysis

The global medical oxygen concentrators market has been categorized on the basis of region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. Based on region, the Americas is expected to dominate the market over the forecast period due to the presence of favorable government initiatives, reimbursement policies, and major market participants developed home healthcare care services and higher adoption of portable oxygen concentrators for homecare needs. Higher value contributors based in the US are Philips Healthcare, Invacare Corporation, AirSep Corporation, ResMed, and Precision Medical, Inc. In addition, government initiatives including the presence of the Federal Aviation Administration (FAA), which authorize the use of portable concentrators during air travel are promoting the dominance of the Americas.

Europe would follow the Americas in terms of revenue over the forecast period as the German government has been undertaking several initiatives to reduce pollution levels in the country and promote public health. In November 2018, the German government unveiled a 5-point plan to reduce plastic waste.

The market in Asia-Pacific would showcase comparatively higher CAGR during the forecast period. This is owing to rising prevalence of COPD and asthma, increasing spending on healthcare, growing awareness about state-of-the-art technologies in an oxygen concentrator, rising adoption of portable units, growth in disposable income, and changing diet pattern and lifestyle resulting in the development of diseases. As per data published in The Lancet journal, in 2016, the prevalence of COPD in India was 4·2% and the prevalence of asthma 2·9%. India has a higher prevalence of COPD than the global average, as well as more disability-adjusted life-years (DALYs) per person with COPD or asthma than the global average.

The Middle East & Africa has the least share of the global medical oxygen concentrators market. In addition, the major market share of the region would be held by the Middle Eastern region due to developing healthcare system and medical infrastructure in the Arab countries.

Browse Full Report Details @ 

https://www.marketresearchfuture.com/reports/medical-oxygen-concentrators-market-7876

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Healthcare Predictive Analytics Market By Trends, Market Share, Industry Size, Opportunities, Analysis and Forecast

The report begins with the overview of the “Healthcare Predictive Analytics Market Research Report – Forecast to 2023” and offers throughout development. It presents a comprehensive analysis of all the regional analysis.

It is estimated that the global healthcare predictive analytics market is expected to register a CAGR ~29.3% during the forecast period of 2018–2023. The global healthcare predictive analytics market is expected to witness tremendous growth owing to the government initiatives to increase EHR adoption, growing venture capital investments, growing pressure to curb healthcare spending and improve patient outcomes. Other key factors such as rising healthcare costs; curb fraudulent claims, optimize provider networks, operational costs; increasing competition, the growing need to increase memberships are compelling healthcare payers to adopt analytics solutions.

Also Read:  https://www.medgadget.com/2020/08/healthcare-predictive-analytics-market-trends-analysis-growth-estimation-future-insights-applications-covid-19-impact-and-business-overview-by-2023.html

However, factors such as lack of trained medical professionals is expected to curb the growth of the market during the forecast period.

On the regional basis, the healthcare predictive analytics market in the Americas is predicted to dominate the market during the forecast period. The North American region holds substantial share in the global market.

This owes to the growth of federal healthcare regulations that curb the rising healthcare costs; rising government initiatives focusing on personalized medicine, growing EHR adoption; and population health management.

For instance, IBM invests a significant amount of its revenue in research activities to continuously improve its product portfolio. The company has invested nearly USD 24 billion in the development of its big data and analytics software and services. The major steps undertaken by the company was the acquisition of Truven Health Analytics in April 2016. This acquisition had assisted the company to acquire a major share of the global market

Currently, the global healthcare predictive analytics market is dominated by numerous players. The major players in this market are involved in new product launches, strategic partnerships, and collaborations to increase their product portfolio. For example, in August 2018, Verscend Technology acquired Cotiviti Holdings, Inc., a leading provider of payment accuracy and analytics-driven solutions focused primarily on the healthcare industry. Also, in July 2018, Health Catalyst acquired Medicity, a PHM company offering solutions for HIEs, business intelligence, and provider and patient engagement.

The global healthcare predictive analytics market is segmented based on component, application, and end user.

Some of the key players in the global intraocular lens market are IBM Corporation (US), Optum, Inc. (US), Cerner Corporation (US), SAS Institute, Inc. (US), Allscripts Health Solutions (US), McKesson Corporation (US), MedeAnalytics, Inc. (US), Inovalon (US), Oracle Corporation (US), Health Catalyst (US), SCIO Health Analytics (US), Verscend Technologies, Inc. (US), CitiusTech, Inc. (US), Wipro Limited (India), and VitreosHealth (US).

For More Details:

https://www.marketresearchfuture.com/reports/healthcare-predictive-analytics-market-7549

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Drug Discovery Informatics Market with Trends, Growth, Scope, Size, Overall Analysis and Prognostication

The research report analyzes the “Drug Discovery Informatics Market Research Report – Forecast to 2023” in a detailed and concise manner for better insights into the businesses

The global drug discovery informatics market held a market value of USD 1,680.6 million in 2017 and is projected to grow at a CAGR of 11.5% over the forecast period. Drug discovery and development is an extremely complex process requiring the generation of very large amounts of information data and. As the pharmaceutical and biotechnology industry is on the rise, information technology is supporting the drug discovery process to improve research productivity and success rates. Patent expiry of blockbuster drugs, an over-reliance on high throughput discovery strategies, and ongoing industry consolidation through mergers and acquisitions (M&A) are fueling the demand for drug discovery informatics. Few of the market growth factors include a worldwide rising focus on drug discovery, growing need to control drug discovery and development costs, rising research and development (R&D) expenditure, and increasing burden of chronic diseases.

Also Read

Introduction of in-silico tools that facilitate computation with varied workflows that are in sync with the rate of modern medicinal chemistry is one of the key trends augmenting market growth. It involves different steps and procedures which depend on in-silico tools for reducing the complexity of the process. In-silico tools include modeling tools for the determination of 3D structures of ligand and protein-absorption, distribution, metabolism, excretion, and toxicity (ADMET) assessment-affinity estimation in docking and drug-ligand interaction for pharmacological profiling.

Regional Analysis

The global drug discovery informatics market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. On the basis of region, the Americas is expected to hold higher market share over the forecast period pertaining to the presence of market value contributors, burgeoning pharmaceutical and biotechnology vertical, and rising prevalence of chronic diseases in the US and Canada. For instance, as per statistics published by the Center for Disease Control and Prevention (CDC), about 610,000 people die due to heart disease in the US every year (one in every four deaths).

Europe would follow the Americas in terms of value in the drug discovery informatics market owing to a surge in the clinical discovery ventures coupled with various activities conducted by research institutes, universities, and centers. The federal government acts as a regulator and also insures some public employees in Germany. Around 16 states in this county maintain public hospitals. The German government also proposes many healthcare programs to make citizens aware of the fatal disease.

Asia-Pacific would represent the fastest market growth during the forecast period owing to growing geriatric population coupled with rising prevalence of chronic diseases, increasing awareness and high adoption of drug discovery informatics, and surging number of clinical trials studies in the region.

The Middle East & Africa has the least share of the global drug discovery informatics market. In addition, the major market share of the region would be held by the Middle Eastern region due to developing healthcare system and medical infrastructure in the Arab countries.

Segmentation

The global drug discovery informatics market has been segmented into product, mode, service, end user, and region.

By product, the market has been segmented into discovery informatics and development informatics.

On the basis of mode, the market has been divided into in-house informatics and outsourced informatics. 

By service, the market has been classified into sequencing and target data analysis, docking, molecular modeling, clinical trial data management, and others. The sequencing and target data analysis segment is expected to dominate the market over the forecast period due to rising application of informatics solutions in targeted analysis and a large amount of data generated during the drug discovery process.

Based on end user, the market has been categorized into pharmaceutical and biotechnology industries, contract research organizations (CROs), and others.

Key Players

Few of the foremost players in the global drug discovery informatics market are Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Certara, L.P., Infosys Limited, Novo Informatics Pvt. Ltd., Collaborative Drug Discovery Inc., Selvita, Charles River Laboratories, Inc., International Business Machines Corporation, Jubilant Life Sciences Ltd., IO Informatics, Inc., GVK Biosciences Private Limited, and Dassault Systèmes.

Access Full Report @ https://www.marketresearchfuture.com/reports/drug-discovery-informatics-market-7831

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com